Articles with "gip" as a keyword



Photo from wikipedia

The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes

Sign Up to like & get
recommendations!
Published in 2020 at "Reviews in Endocrine and Metabolic Disorders"

DOI: 10.1007/s11154-019-09536-6

Abstract: The glucose-dependent insulinotropic polypeptide (GIP) is an incretin hormone produced in the gastrointestinal tract in response to nutrients. GIP has a variety of effects on different systems, including the potentiation of insulin secretion from pancreatic… read more here.

Keywords: gipr axis; gipr; endocrine tumors; gip gipr ... See more keywords
Photo from wikipedia

Canagliflozin Increases Postprandial Total Glucagon-Like Peptide 1 Levels in the Absence of α-Glucosidase Inhibitor Therapy in Patients with Type 2 Diabetes: A Single-Arm, Non-randomized, Open-Label Study

Sign Up to like & get
recommendations!
Published in 2019 at "Diabetes Therapy"

DOI: 10.1007/s13300-019-00689-w

Abstract: To investigate canagliflozin-induced changes in postprandial total glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) levels in patients with type 2 diabetes mellitus (T2DM). Forty-five patients with T2DM who had inadequate glycemic control (glycated… read more here.

Keywords: postprandial total; glp; gip; glucosidase inhibitor ... See more keywords
Photo from wikipedia

The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials

Sign Up to like & get
recommendations!
Published in 2020 at "Diabetes Therapy"

DOI: 10.1007/s13300-020-00981-0

Abstract: Glucagon-like peptide 1 (GLP-1) based therapy is an established treatment option for the management of type 2 diabetes mellitus (T2DM) and is recommended early in the treatment algorithm owing to glycaemic efficacy, weight reduction and favourable cardiovascular… read more here.

Keywords: glp; gip; clinical trials; glp receptor ... See more keywords
Photo from wikipedia

Inhibition of GIP signaling extends lifespan without caloric restriction.

Sign Up to like & get
recommendations!
Published in 2019 at "Biochemical and biophysical research communications"

DOI: 10.1016/j.bbrc.2019.04.036

Abstract: AIMS/INTRODUCTION Caloric restriction (CR) promotes longevity and exerts anti-aging effects by increasing Sirtuin production and activation. Gastric inhibitory polypeptide (GIP), a gastrointestinal peptide hormone, exerts various effects on pancreatic β-cells and extra-pancreatic tissues. GIP promotes… read more here.

Keywords: inhibition gip; caloric restriction; gip signaling; gip ... See more keywords
Photo from wikipedia

Subcutaneous GIP and GLP-2 inhibit nightly bone resorption in postmenopausal women: a preliminary study.

Sign Up to like & get
recommendations!
Published in 2021 at "Bone"

DOI: 10.1016/j.bone.2021.116065

Abstract: BACKGROUND Glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-2 (GLP-2) are gut hormones secreted in response to food ingestion, and they have been suggested to regulate bone turnover. In humans, exogenous GIP and GLP-2 acutely inhibit… read more here.

Keywords: gip glp; gip; bone resorption;
Photo from wikipedia

An oral GLP-1 and GIP dual receptor agonist improves metabolic disorders in high fat-fed mice.

Sign Up to like & get
recommendations!
Published in 2021 at "European journal of pharmacology"

DOI: 10.1016/j.ejphar.2021.174635

Abstract: Dual activation of the glucagon-like peptide 1 (GLP-1) receptor and the glucose-dependent insulinotropic polypeptide (GIP) receptor has potential as a novel strategy for treatment of diabesity. Here, we created a hybrid peptide which we named… read more here.

Keywords: oral glp; fat fed; gip; high fat ... See more keywords
Photo from wikipedia

Different mechanisms of GIP and GLP-1 action explain their different therapeutic efficacy in type 2 diabetes.

Sign Up to like & get
recommendations!
Published in 2020 at "Metabolism: clinical and experimental"

DOI: 10.1016/j.metabol.2020.154415

Abstract: BACKGROUND AND AIMS The reduced action of incretin hormones in type 2 diabetes (T2D) is mainly attributed to GIP insensitivity, but efficacy estimates of GIP and GLP-1 differ among studies, and the negligible effects of… read more here.

Keywords: t2d; type diabetes; gip; gip glp ... See more keywords
Photo by refargotohp from unsplash

Molecular evolution of GIP and Exendin and their receptors

Sign Up to like & get
recommendations!
Published in 2020 at "Peptides"

DOI: 10.1016/j.peptides.2019.170158

Abstract: Glucose-dependent insulinotropic polypeptide (GIP) is a product of the Gip gene and acts as an incretin hormone in mammals. Gip is most closely related to the proglucagon (Gcg) and Exendin genes and diverged from these… read more here.

Keywords: evolution; gip exendin; exendin; gip ... See more keywords
Photo from wikipedia

GIP’s involvement in the pathophysiology of type 2 diabetes

Sign Up to like & get
recommendations!
Published in 2020 at "Peptides"

DOI: 10.1016/j.peptides.2019.170178

Abstract: During the past four decades derangements in glucose-dependent insulinotropic polypeptide (GIP) biology has been viewed upon as contributing factors to various parts of the pathophysiology type 2 diabetes. This overview outlines and discusses the impaired… read more here.

Keywords: pathophysiology type; type diabetes; gip; type ... See more keywords
Photo from wikipedia

Effects on pancreatic Beta and other Islet cells of the glucose-dependent insulinotropic polypeptide

Sign Up to like & get
recommendations!
Published in 2020 at "Peptides"

DOI: 10.1016/j.peptides.2019.170201

Abstract: Glucose-dependent insulinotropic polypeptide (GIP) is a gut-derived incretin that, in common with glucagon-like peptide-1 (GLP-1), has both insulin releasing and extra-pancreatic glucoregulatory actions. GIP is released in response to glucose or fat absorption and acts… read more here.

Keywords: insulinotropic polypeptide; islet; beta; gip ... See more keywords
Photo from wikipedia

The role of GIP in α-cells and glucagon secretion

Sign Up to like & get
recommendations!
Published in 2020 at "Peptides"

DOI: 10.1016/j.peptides.2019.170213

Abstract: Glucose-dependent insulinotropic polypeptide (GIP) is an intestinally derived peptide that is secreted in response to feeding. The GIP receptor (GIPR) is expressed in many cell types involved in the regulation of metabolism, including α- and… read more here.

Keywords: glucagon secretion; gipr activity; secretion; gip ... See more keywords